A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen treatment for women with breast cancer, a new Cambridge-led trial has found. A low ...

The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminizing hormone therapy. This is demonstrated by an ...

Pooled across 34 studies data from 4.5+ million women showed that MHT use increased breast cancer odds by 15% versus non-use, but regimen-specific effects dominated the aggregate estimate.

Women using a certain type of hormone therapy to treat menopause symptoms could be at higher risk for breast cancer, according to a new study. The study, published Tuesday in The Lancet Oncology, ...

A deeper look reveals a different picture. Combined oral contraceptives are composed of the synthetic estrogen ethinylestradiol (primarily to maintain endometrial stability) and a progestin (synthetic ...

One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into ...

Estrogen is one of the primary female hormones, and it serves an important function in both reproductive and overall health. Estrogen supports many important processes, from the development of ...

Menopause brings a lot of change, and it’s normal to feel uncertain about what’s happening in your body. Two of the most important hormone players in this transition are estrogen and progesterone.